title: The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer.
authors.affiliation: Division of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan, hrmukai@east.ncc.go.jp.
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Mukai
authors.forename: Tomohiko
authors.initials: T
authors.lastname: Aihara
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Yamamoto
authors.forename: Masato
authors.initials: M
authors.lastname: Takahashi
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Toyama
authors.forename: Yasuaki
authors.initials: Y
authors.lastname: Sagara
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Yamaguchi
authors.forename: Hiromitsu
authors.initials: H
authors.lastname: Akabane
authors.forename: Junji
authors.initials: J
authors.lastname: Tsurutani
authors.forename: Fumikata
authors.initials: F
authors.lastname: Hara
authors.forename: Tomomi
authors.initials: T
authors.lastname: Fujisawa
authors.forename: Naohito
authors.initials: N
authors.lastname: Yamamoto
authors.forename: Shozo
authors.initials: S
authors.lastname: Ohsumi
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D008593:Menopause; D020360:Neoadjuvant Therapy; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis
chemical_list: D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C508053:ERBB2 protein, human